The business operations conducted within life science companies often involve major risks and opportunities for significant earnings. The risks come not only from the advanced scientific and supervisory environment but also from complicated business models. A key to success is for companies to be able to handle these risks. This demands that the contracts which are produced exhaustively govern all of the risks and that these risks are appropriately allocated between the parties.
NORDIA has a practice group with lawyers experienced in life science to assist national and international companies in the area, both listed companies and private companies.